Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Tags:
Novartis, Chinook Therapeutics, Paratek, Sobi, CTI BioPharma, Astellas, Iveric Bio, Assertio Holdings, Spectrum Pharmaceuticals, Merck, Prometheus Biosciences, Pfizer, Seagen, Sanofi, Provention Bio, Sun Pharma, Concert Pharmaceuticals, BioNTech, InstaDeep, AstraXeneca, CinCor Pharma, Ipsen, Albireo, Chiesi, Amryt, Moderna Therapeutics, OriCiro Genomics
Hope springs for April inhibition
EP Vantage
Tue, 06/13/23 - 10:27 am
Tags:
Novartis, Chinook Therapeutics, April inhibition, M&A, Vera Therapeutics, Otsuka, RemeGen, Alpine Immune Sciences, Akso Biopharmaceutical, Aurinia Pharmaceuticals
Novartis to acquire kidney disease biotech Chinook for up to $3.5B
BioPharma Dive
Mon, 06/12/23 - 10:24 am
Tags:
Novartis, Chinook Therapeutics, M&A, kidney disease
EHA 2023 – Astrazeneca keeps up its complement defense
EP Vantage
Fri, 06/9/23 - 10:01 am
Tags:
EHA, AstraZeneca, Alexion, Soliris, Ultomiris, Novartis, iptacopan, PNH
Novartis debuts hidradenitis suppurativa docuseries at Tribeca Film Festival
Medical Marketing and Media
Thu, 06/8/23 - 09:44 pm
Tags:
Novartis, hidradenitis suppurativa, documentary, pharma marketing
Sandoz hitches its wagon to biosimilars, predicting $3B in sales from pipeline products over next 5 years
Fierce Pharma
Thu, 06/8/23 - 09:29 pm
Tags:
Novartis, Sandoz, generics, biosimilars
ASCO in Review: Oncologists See Practice-Changing, Affirming Data
BioSpace
Thu, 06/8/23 - 09:26 pm
Tags:
ASCO 2023, oncologists, cancer, AstraZeneca, Tagrisso, non-small cell lung cancer, Novartis, Kisqali, breast cancer, Merck, Keytruda, Moderna Therapeutics, cancer vaccine
After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints
Fierce Biotech
Wed, 06/7/23 - 10:15 am
Tags:
Merck, Inflation Reduction Act, legal, drug pricing, Biogen, Novartis, Genentech, BIO 2023
Novartis drug helps stop breast cancer’s return in large study
BioPharma Dive
Fri, 06/2/23 - 11:24 am
Tags:
Novartis, Kisqali, clinical trials, breast cancer
As Sandoz prepares to spin off from Novartis, the company sets sights on new crosstown headquarters
Fierce Pharma
Thu, 06/1/23 - 06:35 pm
Tags:
Novartis, biosimilars, spinoffs, headquarters
Novartis buys priority review voucher from Pharming for discount price of $21M
Fierce Biotech
Thu, 06/1/23 - 11:40 am
Tags:
Novartis, Pharming, priority review vouchers
ASCO preview: Merck's Keytruda, Novartis' Kisqali face their moment of truth in early-stage cancers
Fierce Pharma
Thu, 05/25/23 - 08:33 pm
Tags:
ASCO 2023, Merck, Keytruda, Novartis, Kisqali, non-small cell lung cancer, early breast cancer
Novartis to buy Avrobio gene therapy for $88M, leaving rest of the biotech on the shelf
Fierce Biotech
Mon, 05/22/23 - 11:35 am
Tags:
Novartis, gene therapy, Avrobio, AVR-RD-04
Novartis brings on 8 business vets for Sandoz's new board, including 4 women
Fierce Pharma
Tue, 05/16/23 - 12:12 pm
Tags:
Novartis, Sandoz, biosimilars, generics, women executives
The waxing and waning of the speedy approval
EP Vantage
Mon, 05/15/23 - 09:58 am
Tags:
FDA, drug approvals, accelerated approvals, AbbVie, AstraZeneca, Bayer, Bristol Myers Squibb, JNJ, Merck, Merck KGaA, Novartis, Pfizer
Sandoz taps Evotec in long-term biosimilar development and manufacturing deal
Fierce Pharma
Wed, 05/10/23 - 10:00 am
Tags:
Novartis, Sandoz, Evotec, biosimilars
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
Tags:
AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Eli Lilly, Gilead Sciences, Horizon Therapeutics, Merck, Moderna Therapeutics, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi
Biogen, Novartis, Sanofi Cull Candidates in Q1 Pipeline Reprioritizations
BioSpace
Fri, 05/5/23 - 12:09 pm
Tags:
Biogen, Novartis, Sanofi, earnings, R&D
Novartis spruces up Sandoz—again—by bringing 6 new US generics into the fold
Fierce Pharma
Thu, 05/4/23 - 09:00 pm
Tags:
Novartis, Sandoz, generics, Adalvo
'More in the hopper': European Big Pharmas hint M&A could ramp up
Fierce Biotech
Mon, 05/1/23 - 10:15 am
Tags:
Europe, M&A, GSK, Novartis, Roche

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.